Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
Store
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Craig H. Mallinckrodt, PhD: Simple Options for Improving Signal Detection in Antidepressant Clinical Trials
$
30.00
Add to cart
Details
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
$
30.00
Add to cart
Details
Critical Analysis of Recent Phase III Studies for the Treatment of Colorectal Cancer Implications for Future Clinical Trial Design
$
10.00
Add to cart
Details
Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
$
30.00
Add to cart
Details
DASS21
$
0.00
Add to cart
Details
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression
$
30.00
Add to cart
Details
David C. Steffens, MD, MHS: The Duke Somatic Treatment Algorithm for Geriatric Depression (STAGED) Approach
$
30.00
Add to cart
Details
David M. Lyons, PhD: Stress, Depression, and Inherited Variation in Primate Hippocampal and Prefrontal Brain Development
$
30.00
Add to cart
Details
David V. Sheehan, MD, MBA: Current Approaches to the Pharmacologic Treatment of Anxiety Disorders
$
30.00
Add to cart
Details
David V. Sheehan, MD, MBA: The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder
$
30.00
Add to cart
Details
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
$
30.00
Add to cart
Details
Deanna L. Kelly, PharmD, BCPP: Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations
$
30.00
Add to cart
Details
Delayed-Onset Toxicity in an Adolescent Case Following Attempted Suicide with an Overdose of Paliperidone Intake
$
30.00
Add to cart
Details
Demographic and Clinical Characteristics of Antipsychotic Drug-Treated Older Adults with Bipolar Disorder from the Global Aging & Geriatric Experiments in Bipolar Disorder Database (GAGE –BD)
$
30.00
Add to cart
Details
Demographic Variation in the Use of Prazosin for Treatment of Sleep Disturbance in Combat Veterans with PTSD
$
30.00
Add to cart
Details
Depression in the Elderly
$
30.00
Add to cart
Details
Depression Rating Scales – A Doctor’s Guide
$
15.00
Add to cart
Details
Depression Treatment: A Lifelong Commitment?
$
30.00
Add to cart
Details
Desvenlafaxine and Venlafaxine Exert Minimal In Vitro Inhibition of Human Cytochrome P450 and P-Glycoprotein Activities
$
30.00
Add to cart
Details
Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a Primer
$
30.00
Add to cart
Details
Developing and Testing Adaptive Treatment Strategies Using Substance-Induced Psychosis as an Example
$
30.00
Add to cart
Details
Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder
$
30.00
Add to cart
Details
Development of Antagonists of the Platelet-Derived Growth Factor Receptor Family
$
0.00
Add to cart
Details
Development of STI571 and Its Use in Chronic Myelogenous Leukemia and Other Malignancies
$
0.00
Add to cart
Details
Dextromethorphan in Cough Syrup: The Poor Man’s Psychosis
$
30.00
Add to cart
Details
Diagnosis and Staging of Gynecological Malignancies
$
0.00
Add to cart
Details
Diagnosis and Treatment of Depression in the Cancer Patient
$
0.00
Add to cart
Details
Diferencias de género en el trastorno depresivo mayor y el trastorno bipolar
$
0.00
Add to cart
Details
Differences in Efficacy on Substance Abuse between Risperidone and Clozapine
$
30.00
Add to cart
Details
Divalproex and Epilepsy
$
30.00
Add to cart
Details
Divalproex in the Treatment of Bipolar Disorder
$
30.00
Add to cart
Details
Divalproex in the Treatment of Migraine
$
30.00
Add to cart
Details
Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
$
30.00
Add to cart
Details
Does Isotretinoin Cause Depression and Suicide? By J. Douglas Bremner, MD
$
0.00
Add to cart
Details
Donald S. Robinson, MD: Monoamine Oxidase Inhibitors: A New Generation
$
30.00
Add to cart
Details
Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
$
30.00
Add to cart
Details
Dose-Dependent Urinary Incontinence with Sertraline Use in Obsessive-Compulsive Disorder
$
30.00
Add to cart
Details
Douglas G. Kondo, MD: An Evidence-Based Medicine Approach to Combined Treatment for ADHD in Children and Adolescents
$
30.00
Add to cart
Details
Dr. Juan E. Mezzich y Dr. Miguel R. Jorge: ¡Bienvenidos a Psiquiatría y Salud Integral!
$
0.00
Add to cart
Details
Drug Development for Anxiety Disorders: New Roles for Atypical Antipsychotics
$
30.00
Add to cart
Details
Drug Induced Mania in a Boy with High Functioning Autism
$
30.00
Add to cart
Details
Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
$
30.00
Add to cart
Details
Duloxetine for the Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
Duloxetine in Military Posttraumatic Stress Disorder
$
30.00
Add to cart
Details
Duration of Untreated Illness in Obsessive-Compulsive Disorder and its Associated Factors
$
30.00
Add to cart
Details
E. Chris Muly, MD, PhD: Signal Transduction Abnormalities in Schizophrenia: the cAMP System
$
30.00
Add to cart
Details
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Economic Impacts of Anxiety Disorders
$
0.00
Add to cart
Details
Economics of Cancer Drug Development
$
0.00
Add to cart
Details
EDITOR’S LETTER: Charles B. Nemeroff, MD, PhD
$
0.00
Add to cart
Details
Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
$
30.00
Add to cart
Details
Eduardo J. Aguilar, MD, PhD: Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?
$
30.00
Add to cart
Details
Effect of Milnacipran on Plasma Level of Vascular Endothelial Growth Factor in Major Depression
$
30.00
Add to cart
Details
Effect of Mirtazapine Orally Disintegrating Tablets on Health-Related Quality of Life in Elderly Depressed Patients with Comorbid Medical Disorders: A Pilot Study
$
30.00
Add to cart
Details
Effective Vortioxetine Dose Varies with Extent of Antidepressant Use Across Countries
$
30.00
Add to cart
Details
Effectiveness of a Brain-Computer Interface Based Programme for the Treatment of ADHD: A Pilot Study
$
30.00
Add to cart
Details
Effectiveness of Clozapine use in Delaying Hospitalization in Routine Clinical Practice: A 2 year Observational Study
$
30.00
Add to cart
Details
Effects of Discontinuation of Paliperidone Long-Acting Injectable After Switching from Risperidone Long-Acting Injectable Switching
$
30.00
Add to cart
Details
Effects of Venlafaxine on the Size of Brain and Expression of SHANK3, TUBB5 and DDC Genes in BALB/c Mice
$
30.00
Add to cart
Details
Efficacy and Tolerability of Controlled-Release Paroxetine
$
30.00
Add to cart
Details
Previous
1
…
3
4
5
…
15
Next
Page load link
Go to Top
